Published in Alcohol Clin Exp Res on April 15, 2008
The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal (2009) 1.72
Non-invasive markers for hepatic fibrosis. BMC Gastroenterol (2011) 1.65
Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol (2011) 1.52
Non-invasive assessment of liver fibrosis. Ann Gastroenterol (2012) 1.07
The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters. Am J Transl Res (2013) 0.93
Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease. Comp Hepatol (2012) 0.86
Tenascin-C: Exploitation and collateral damage in cancer management. Cell Adh Migr (2015) 0.85
Tenascin-C: a novel mediator of hepatic ischemia and reperfusion injury. Hepatology (2011) 0.83
Tenascins in fibrotic disorders-from bench to bedside. Cell Adh Migr (2015) 0.81
Inhibition of fibrous adhesion formation in the temporomandibular joint of tenascin-C knockout mice. Eur J Histochem (2014) 0.81
Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis. Acta Pharmacol Sin (2014) 0.80
Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. World J Gastroenterol (2015) 0.78
Carbohydrate Deficient Transferrin and Interleukin-6 as Predictors of Fibrosis in Alcohol Cirrhosis. Indian J Clin Biochem (2015) 0.75
Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis. Sci Rep (2015) 0.75
Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med (2005) 5.88
Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med (2005) 4.38
Five-year colon surveillance after screening colonoscopy. Gastroenterology (2007) 3.74
Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc (2002) 3.16
Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA (2003) 2.68
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology (2010) 1.95
First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer. Clin Gastroenterol Hepatol (2003) 1.73
Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol (2006) 1.18
Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival. Gastroenterology (2005) 1.15
II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res (2003) 1.14
I. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams. Alcohol Clin Exp Res (2003) 1.03
Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area. Am J Gastroenterol (2002) 0.97
Colonoscopy withdrawal time and risk of neoplasia at 5 years: results from VA Cooperative Studies Program 380. Am J Gastroenterol (2010) 0.96
Cytokeratin 7 staining of hepatocytes predicts progression to more severe fibrosis in alcohol-fed baboons. J Hepatol (2003) 0.78